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Background: Recent cross-sectional studies have suggested a dose-dependent rela-
tionship between lifelong exposure to physical activity and the burden of calcified 
coronary artery disease (CAD). No longitudinal studies have addressed this concern.
Hypothesis: Exercise volume is associated with progression of coronary artery cal-
cium (CAC), defined as ≥10 units increase in CAC score.
Methods: Sixty-one recreational athletes who were assessed by coronary computed 
tomography angiography (CCTA) as part of the NEEDED 2013/14 study were re-
assessed 4-5 years later, in 2018.
Results: Subjects were 45.9 ± 9.6 years old at inclusion, and 46 (74%) were male. 
Between 2013 and 2018, the participants reported median 5 (range: 0-20, 25th-75th 
percentile: 4-6) hours of high-intensity exercise per week. None of the included sub-
jects smoked during follow-up. At inclusion, 21 (33%) participants had coronary artery 
calcifications. On follow-up CCTA in 2018, 15 (25%) subjects had progressive coro-
nary calcification (≥10 Agatston units increase in CAC). These subjects were older 
(53 ± 9 vs 44 ± 9 years old, P = .002) and had higher levels of low-density lipoprotein 
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1 |  INTRODUCTION
The presence of coronary artery calcification is associated 
with increased risk of adverse cardiovascular events.1,2 Despite 
beneficial effects of physical activity on cardiovascular (CV) 
morbidity and mortality, recent studies have demonstrated a 
surprisingly high prevalence of coronary artery calcium (CAC) 
in 40%-68% of recreational athletes.3-5 These studies have sug-
gested a dose-dependent relation between lifelong exposure to 
physical activity and calcified coronary artery disease (CAD).3-
6 This relationship, however, may seem contra intuitive, based 
upon the health and longevity of athletic subjects.
No previous study has used repeated coronary computed 
tomography angiography (CCTA) to monitor changes in 
CAC in recreational athletes. The present study aimed to 
assess the impact of exercise volume on the progression of 
CAC, defined as ≥10 units increase in CAC score (Agatston 
units) during >4-year follow-up in middle-aged recreational 
athletes without known CV disease prior to baseline CCTA 
assessment.
2 |  MATERIAL AND METHODS
The present analysis is a sub-study of the North Sea Race 
Endurance Exercise Study (NEEDED) 2018. We assessed 
the change in CAC between the baseline CCTA acquired in 
either the NEEDED 2013 or 2014 study 7,8 and the follow-up 
CCTA assessment in 2018 (Figure S1). NEEDED 2018 was 
approved by the Regional Ethics Committee (REK 2013/550 
and REK 2018/63), in compliance with the Declaration of 
Helsinki. All participants signed informed consent forms 
prior to enrollment into the studies.
In order to be included in the NEEDED study program, 
subjects had to be >16 years of age, reside in Norway and 
participate in the 91-km-long recreational mountain bike race 
(The North Sea Race). Subjects were excluded if they had 
known CV disease or CV medication, or if they had a rest-
ing ECG suggestive of underlying pathology at screening.9 
Study subjects were assessed by electrocardiograms (ECG), 
clinical assessments, and blood samples at baseline and at 3- 
and 24 hours after the race. Study recruitment is outlined in 
Figure S1. In total, 61 subjects completed the NEEDED 2018 
study protocol. Only participants without obstructive CAD 
at baseline CCTA were eligible to participate in NEEDED 
2018. In NEEDED 2018, a cardiopulmonary exercise test 
was conducted prior to the cycling competition. All study 
participants in NEEDED 2018 were assessed by coronary 
computed tomography angiography (CCTA) within 1 month 
after the race. Progression of coronary artery calcium (CAC) 
score was defined as an increase above the 75th percentile of 
Δ CAC in the present cohort, corresponding with Δ CAC of 
≥10 Agatston units. Linear regression was also performed, 
but due to skewed distribution of Δ CAC, logistic regression 
was preferred. Training volume was defined as self-reported 
number of hours per week of high-intensity exercise (>6 met-
abolic equivalents of task [MET] per minute) in the years be-
tween 2013 and 2018.
2.1 | Cardiopulmonary exercise test
The cardiopulmonary exercise test (CPET) was performed 
2-3  weeks prior to the North Sea Race in 2018, using the 
“Cyclus 2” and “Vyntus CPX” systems. This enabled sub-
jects to perform the test on their own bikes. Individual ramp 
protocols, a face-covering mask, and a heart rate monitor 
were used to obtain data. Continuous gas analysis was done 
by using a mixing chamber gas analyzer. Subjects reached 
VO2max when a plateau in oxygen consumption occurred, as 
well as a respiratory exchange ratio above 1.05 and BORG 
score >18. VO2max was adjusted for age and gender by com-
parative data from a Norwegian cohort.10 One person did not 
achieve a plateau in oxygen consumption during testing. For 
at baseline (3.5 (2.9-4.3) vs 2.9 (2.3-3.5) mmol/L, P = .031) as compared to subjects 
with stable condition. No relationship was found between hours of endurance training 
per week and progression of coronary artery calcification. In multiple regression analy-
sis, age and baseline CAC were the only significant predictors of progressive CAC.
Conclusion: No relationship between exercise training volume and the progression 
of coronary artery calcification was found in this longitudinal study of middle-aged 
recreational athletes.
K E Y W O R D S
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this person, peak VO2 was recorded as the maximal VO2 at 
exhaustion.
2.2 | Blood samples
Venous blood samples were drawn from the antecubital 
vein. Fresh serum samples were analyzed for creatinine, 
high-sensitive C-reactive protein (CRP), low-density li-
poprotein (LDL), and high-density lipoprotein (HDL) 
on Architect c16000TM (Abbott Diagnostics). High-
sensitive cTnI was analyzed by a STAT assay from Abbott 
Diagnostics using Architect I2000SR. The cTnI assay had 
a limit of detection of 1.6 ng/L, and the overall 99th per-
centile was 26  ng/L.11 Hematology was analyzed using 
XE-5000 (Sysmex XN).
2.3 | Coronary computed tomography 
angiography
CCTA was obtained using a Siemens Somatom Definition 
Flash Dual Source, with the same protocol as for the 
NEEDED 2013-2014 studies.7 Slice acquisition parameter 
was 0.6 × 128 mm. Those with heart rate more than 60 beats 
per minute were given atenolol or metoprolol tartrate prior 
to examination. All were given 0.8 mg nitroglycerine sublin-
gual before the scan. A scout scan was performed from under 
the tracheal bifurcation to the diaphragm, followed by CT 
calcium score scans with gantry rotation 280 ms, 120 kV, and 
80 mAs. A two-phase injection of Omnipaque 350 mg/mL 
at a rate of 6 ml/sec followed by 0.9% saline with high pitch 
or prospectively ECG triggered protocols was administered. 
CCTA was reconstructed with a slice thickness of 0.6 mm 
medium smooth tissue convolution and iterative reconstruc-
tion. Two independent radiologists with more than 5 years 
of experience in CCTA did the CAC analysis on SyngoVia 
cardiac work stations adhering to the guidelines on interpret-
ing and reporting CCTA.12
2.4 | Statistical analysis
Normally, distributed variables were reported as mean ± SD, 
while continuous variables with markedly skewed distribu-
tions were reported as median (25th-75th percentile). The 
Shapiro-Wilk test was used to test for normality. A two-
tailed P-value of <0.05 was considered significant. The 
Mann-Whitney U test, Person chi-square test, or Fisher's 
exact test were used to assess differences between subjects 
with stable condition vs subjects with progression of CAC, 
as appropriate. For the multiple logistic regression analysis, 
the Hosmer-Lemeshow test was used to assess goodness 
of fit, with a P-value threshold of >0.05 for model accept-
ance. The following pre-specified variables were included 
in the multiple regression analysis: age, gender, baseline 
LDL, baseline BMI, baseline systolic blood pressure (SBP), 
and exercise volume per week during the follow-up period. 
A separate model (Model 2) was also calculated, which in-
cluded the same variables as in Model 1, but also adjusted 
for the baseline CAC score. This was done in order to iden-
tify possible associations that could be obscured by including 
baseline CAC.13 No more variables were considered appro-
priate in the multiple regression analysis due to the moderate 
sample size (n  =  61). A linear regression analysis with Δ 
CAC + 1 was also performed, using the same variables as in 
the presented logistic regression analysis. Residual analysis 
improved with Ln transformation of the dependent variable, 
but was still slightly skewed. For statistical analysis, the sta-
tistical software program SPSS version 24 was used.
3 |  RESULTS
Baseline characteristics of the total cohort (n = 61) are out-
lined in Table 1. In short, subjects were 46 ± 10 years old and 
46 (74%) were male. The cohort had a low CV risk profile 
(Framingham Risk Score: 1 [0-5] %). Study subjects reported 
median 5 (4-6) hours/week of high-intensity exercise in the 
period between baseline and 2018, and 56 (33-106) MET 
hours per week (Figure 1).
At baseline, the median CAC score was 0 (0-6) Agatston 
units. Forty subjects (66%) had normal coronary arteries with-
out CAC or non-calcified plaques. In subjects with CAC, 13 
(62%) had calcified plaques only (Table 2). On follow-up CCTA 
in 2018, 15 subjects had an increased CAC score (≥10 Agatston 
units) as compared to the baseline CCTA examination.
The overall median Δ CAC from baseline to the 2018 
CCTA was 0 (25th-75th percentile: 0-10) Agatston units 
(mean 15 ± 40 Agatston units, Figure 2). In the group with 
stable condition, the median Δ CAC score was 0 (0-0.1), 
while in the subjects with progressive CAC, median Δ CAC 
was 28 (12-105) Agatston units (Table 3).
New CAC in 2018 occurred in six subjects with no CAC at 
baseline (Table 2). The median Δ CAC in these subjects was 
5 (3-12) Agatston units. The only subject with a CAC pro-
gression exceeding 10 Agatston units (CAC of 20 Agatston 
units in 2018) was a 37-year-old male with a non-calcified 
plaque on the baseline CCTA examination in 2014.
3.1 | Differences between subjects with 
stable condition vs progressive CAC score
Compared with subjects without CAC progression, sub-
jects with CAC progression (n = 15) were older (53 ± 9 vs 
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44 ± 9 years old, P = .002) and had a higher FRS (4 [1-12] vs 0 
[0-2] %, P = .007) and higher levels of low-density lipoprotein 
(LDL) (3.5 [2.9-4.3] vs 2.9 [2.3-3.5] mmol/L, P = .031). None 
of the included subjects were current smokers at inclusion, and 
a similar number of subjects in both groups had a history of to-
bacco use (P = .78). All of the 15 subjects with CAC progres-
sion had CAD at baseline, with 7 (47%) having CAD in two or 
more of the epicardial coronary arteries (Table 2).
During follow-up, both groups had similar changes in 
body composition, blood pressure, CRP level, and kidney 
function. Borderline significant differences in resting cTnI 
level were found, with subjects with progression of CAC 
showing a slight increase (P =  .07). LDL decreased in the 
group with progression of CAC, but when subjects with cur-
rent statin-use were excluded (n = 8), similar cholesterol lev-
els were evident in both groups (Table 3).
In multiple regression analysis, age and baseline CAC 
score were associated with an increased risk of progression 
of CAC (Table 4, Table S1).
3.2 | Endurance exercise and progression of 
CAC score
Both groups reported similar number of prior endurance 
competitions and similar MET hours per week at baseline 
(Table  1). Both groups had similar race performance at 
baseline (3.9 [3.2-4.1] vs 3.6 [3.4-4.0] hours, P  =  .56). 
No significant differences in reported MET hours or race 
performance between the two groups were evident in 
2018 (Table  2). In addition, there was no difference in 
maximal VO2 level in 2018 between those with progres-
sion of CAC vs those with stable condition (38.8 ± 7.0 vs 
42.4 ± 8.9 mL/kg/min, P = .23, as percent of expected, ad-
justed for age and sex: 97.3 ± 16 vs 100 ± 20%, P = .57). 
Reported MET hours/week at inclusion and hours of en-
durance training per week during the follow-up period 
correlated well (rho = 0.60, P < .001). MET hours/week 
reported in 2018 and hours of endurance training had a 






Age, years 45.9 ± 9.6 44.3 ± 8.9 52.9 ± 9.4 .002
Male sex, n (%) 46 (74) 33 (72) 12 (80) .74
BMI, kg/m2 24.3 (23.5-26.6) 24.5 (23.7-25.9) 24.3 (24.1-26.7) .56
Waist circumference, cm 83 (78-89) 82 (78-89) 84 (80-91) .29
SBP, mm Hg 140 ± 18 138 ± 16 145 ± 26 .33
DBP, mm Hg 81 ± 11 79 ± 12 84 ± 10 .34
Former smoker, n (%) 28 (45) 22 (48) 6 (40) .77
Family history of CVD 4 (7) 2 (4) 2 (13) .26
FRS, % 1 (0-5) 0 (0-2) 4 (1-12) .007
Baseline blood samples
LDL, mmol/L 3.0 (2.5-4.1) 2.9 (2.3-3.5) 3.5 (2.9-4.3) .03
HDL, mmol/L 1.6 (1.3-1.8) 1.6 (1.3-1.8) 1.6 (1.2-1.8) .80
CRP, mg/L 0.5 (0.4-1.2) 0.7 (0.3-1.3) 0.4 (0.4-0.5) .14
eGFR, mL/min/1.73m2 91 (81-100) 89 (81-100) 96 (83-100) .88
Hemoglobin, g/dL 14.3 ± 0.9 14.2 ± 0.9 14.5 ± 0.8 .35
Glucose, mmol/L 5.3 (4.8-5.6) 5.2 (4.8-5.5) 5.6 (4.5-5.9) .48
cTnI, ng/L 3.1 (1.7-7.0) 2.3 (1.6-6.4) 6.1 (2.7-10.1) .14
Training experience
Years of endurance 
training
10 (6-35) 5 (3-8) 9 (3-30) .06
Number of prior 
competitions
9 (3-15) 7 (3-12) 10 (3-21) .41
MET h/wk 56 (33-106) 50 (34-82) 68 (33-122) .16
Race duration, h 3.7 (3.4-4.0) 3.6 (3.4-4.0) 3.9 (3.2-4.1) .56
Abbreviations: BMI, body mass index; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; 
FRS, Framingham Risk Score; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MET, metabolic 
equivalents of task (obtained by the IPAQ-SF questionnaire).
T A B L E  1  Baseline characteristics, 
n = 61
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During the follow-up period, both groups reported 5 
(4-6) hours of high-intensity endurance exercise training 
per week. There was no association with high volumes 
of high-intensity endurance exercise training and pro-
gression of CAC in either unadjusted (OR  =  0.99 [0.82-
1.19], P  =  .88) or in adjusted models (Table  4, Figure  2, 
Figure S2). No association with exercise volume was found 
in a sensitivity analysis conducted with Δ CAC + 1 as the 
dependent variable (Table S1).
3.3 | Statin therapy
Subjects were excluded if they were taking statins prior to 
inclusion. However, following the baseline CCTA, the 21 
subjects with CAD at baseline were advised to start statin 
therapy. In 2018, only 8 subjects reported that they were cur-
rently taking a statin, two of whom had started statin therapy 
during the follow-up period independently of findings on 
F I G U R E  1  Exercise distribution. 
Distribution of hours of endurance exercise 
training per week among the included 
subjects with (black) and without (gray) 
progression of CAC (≥10 Agatston units)
T A B L E  2  Coronary artery disease (CAD) and coronary artery calcium (CAC) at baseline and at follow-up CCTA in 2018
 









Any CAD 6 (13) 15 (100) <.001 11 (27) 15 (100) <.001
Calcified plaques 5 (83) 8 (53)   9 (82) 11 (73)  
Non-calcified plaques 1 (17) 1 (7)   0 (0) 0 (0)  
Mixed morphology 0 (0) 6 (40) .18 2 (18) 4 (27) 1.00
Number of affected arteries
Normal arteries 40 (87) 0 (0)   35 (76) 0 (0)  
1 artery affected 6 (13) 8 (53)   10 (22) 4 (27)  
≥2 affected arteries 0 (0) 7 (47) <.001 1 (2) 11 (73) <.001
CAC, Agatston units 0 (0-0) 22 (3-58) <.001 0 (0-0.13) 40 (21-142) <.001
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CCTA at baseline (both had normal coronary arteries). As 
such, 15 subjects had discontinued the drug during follow-
up. There was no significant difference in current statin ther-
apy between the subjects with stable condition and those who 
had progression of CAC (Table 2).
4 |  DISCUSSION
This is the first longitudinal coronary computed tomography 
angiography (CCTA) study to assess the progression of coro-
nary artery calcification (CAC) in recreational athletes. There 
are several important findings: First, the volume of endur-
ance exercise training was not associated with progression of 
CAC. Second, the prevalence of CAC was less in the present 
cohort of highly active middle-aged subjects compared with 
previously published studies on well-trained subjects. Third, 
the progression of CAC was associated with age and with 
baseline coronary artery disease (CAD).
4.1 | Clinical consequences of coronary 
artery calcium (CAC)
The presence of CAC assessed by CCTA is associated 
with increased risk of clinical events.1,2 It has therefore 
raised concern when previous studies have demonstrated 
a higher prevalence of CAC among recreational ath-
letes than in age- and gender-matched sedentary popu-
lations.3,5,6 Although CAC is a marker of the burden of 
coronary artery atherosclerosis, assessment of CAC does 
not identify vulnerable plaques, that is, plaques with large 
necrotic cores, and macrophage infiltration in the fibrous 
cap. Subjects with purely calcified plaques may have less 
F I G U R E  2  CAC progression on 
CCTA. Examples of progression of CAC 
from inclusion (2013/14) to follow-up in 
2018; 1A, Left anterior descending artery 
(LAD) in a 51-year-old male in 2014; 1B, 
LAD in the same male in 2018; 2A, Right 
coronary artery (RCA) in a 58-year-old 
female at inclusion (2014); 2B, RCA in 
the same female in 2018; 3A, LAD of a 
55-year-old male at inclusion in 2014; 3B, 
LAD of the same male in 2018. Subject 
1 exercised less than 2 h per week during 
follow-up, while subjects 2-3 exercised 
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clinical events than subjects with non-calcified or mixed 
plaques.14 Calcified coronary plaques may consequently 
be considered more stable than non-calcified and mixed 
plaques.14,15 Statin therapy for CAD decreases all-cause 
and cardiovascular mortality, but concomitantly, statin 
therapy is associated with increased CAC.13,16-19 It has 
been suggested that the increased prevalence of CAC 
among recreational athletes might be indicative of a simi-
lar plaque stabilizing effect of exercise.3,5
Exercise has been hypothesized to increase CAC due to 
shear stress forces and a hyperdynamic coronary circulation 
causing non-laminar flow.3,5 Exercise-induced hypertension, 
systemic inflammation with repeated bouts of exercise, and 
exercise-induced parathyroid hormone increases may also 
increase CAC formation.5,20 In the present study, we found 
no relationship between exercise training volume and the 
progression of CAC in either logistic regression analysis 
(Table 4) or in linear models (Table S1). Similarly, there was 
no relationship between progression of CAC and the other ex-
ercise variables explored. In line with previous publications, 
age and baseline CAC were major predictors of progression 
of CAC.13,21,22 Our findings suggest that the progression of 
CAC rather reflects underlying CV risk factors and CAD 






Δ BMI, kg/m2 0.3 (−0.6-1.1) 0.4 (−0.1-1.4) .38
Δ Waist circumference, cm 4 (−0.5-7.2) 6 (2-11) .18
Δ SBP, mm Hg -4 ± 12 -4 ± 22 .60
Δ DBP, mm Hg 2 ± 10 0 ± 11 .44
On statin therapy in 2018, n 
(% of subjects with CAD at 
baseline)
1 (17) 5 (33) .62
Blood sample changes
Δ LDL, mmol/L 0.2 (−0.2-0.6) -0.2 (−1.7-0.2) .02
Δ LDL (non-statin users 
only), mmol/L
0.2 (−0.1-0.7) 0.1 (−0.2-0.5) .26
Δ HDL, mmol/L -0.1 (−0.2- 0.0) -0.1 (−0.2-0) .41
Δ CRP, mg/L 0.2 (0-0.7) 0.2 (0-1.1) .50
Δ eGFR, mL/min/1.73m2 3.6 (−0.4-13.1) 3.8 (−1.8-7.1) .65
Δ Glucose, mmol/L 0.3 (−0.5-1.1) 0.4 (−0.9-1.2) .91
Δ Resting cTnI, ng/L -0.1 (−0.7-1.8) 1.1 (0.3-2.9) .07
Exercise parameters
Δ MET h/wk 10 (−5-25) -11 (−24-27) .35
Δ Race duration, h 0.4 (0.2-0.7) 0.5 (0.2-0.5) .99
CCTA indices 2018
Δ CAC, Agatston units 0 (0-0.1) 28 (12-105) <.001
Note: Data are presented as mean ± SD or median (25th-75th) percentile, whenever appropriate.
T A B L E  3  Changes in markers of 
cardiovascular risk between inclusion 
(2013/14) and follow-up (2018) in the group 
with stable condition vs the group who had 
progressive CAD
 
Model 1 Model 2
OR (95% CI) P-value OR (95% CI) P-value
Endurance training 2013-18, 
h/wk
1.02 (0.81-1.29) .85 0.97 (0.62-1.50) .87
Age, y 1.14 (1.03-1.25) .009 1.03 (0.90-1.18) .67
Male gender 1.16 (0.20-6.84) .87 1.23 (0.12-13.0) .86
LDL at baseline, mmol/L 1.32 (0.58-3.00) .51 0.77 (0.22-2.55) .67
BMI at baseline, kg/m2 0.98 (0.73-1.33) .92 1.02 (0.66-1.56) .94
SBP at baseline, mm Hg 0.99 (0.95-1.03) .61 1.00 (0.96-1.05) .96
Baseline CAC, Agatston units     82.1 (6.0-1122.2) .001
Note: Baseline CAC only included in Model 2.
T A B L E  4  The relationship between 
hours of endurance exercise training per 
week and adjusted odds ratio (OR) of having 
≥10 units increase in CAC score (n = 15) at 
follow-up when reporting high volumes of 
endurance exercise
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4.2 | The prevalence and 
progression of coronary artery calcium (CAC) 
in recreational cyclists
In the present cohort, the prevalence of CAC at baseline was 
34%, with a median CAC of 0 (0-6) Agatston units. For sub-
jects with CAC at baseline, the median CAC was 12 (3-37) 
Agatston units. Thus, the baseline CAC score in the present 
cohort was comparable with the CAC scores in similar age 
groups from other population-based cohorts,23,24 but lower 
than previously reported in highly active subjects.3-6,25 During 
the 4.1 ± 0.3 years of follow-up, only 15 subjects (25%) had 
progression of CAC ≥ 10 Agatston units. The mean Δ CAC 
was 15 ± 40 Agatston units. This rate of progression of CAC 
was modest compared with other studies of the progression of 
CAC on CCTA.13,21,22,26-28 In the Heinz Nixdorf Recall Study 
(HNRS), subjects 45-50 years of age had a mean Δ CAC pro-
gression of 38 Agatston units over a 5-year period.21 In HNRS, 
authors reported that once the CAC process had begun, the 
progression of CAC followed an exponential trajectory.21
In previous studies, age, gender, and baseline CAC score 
explained 80% of the variance of CAC progression in men and 
72% of the variance of CAC progression in women. Additional 
adjustment for baseline risk factors only increased the ex-
plained variance by 1%-3%.21 In the present study, age was a 
significant predictor of CAC progression in univariable and 
the simplest multiple regression models, but was no longer a 
significant predictor factor in multiple regression models in-
cluding baseline CAC. Furthermore, all subjects with CAC 
progression during follow-up had some degree of CAC or CAD 
at baseline. Subjects with CAC progression had a decrease in 
LDL levels during follow-up; however, this finding was abol-
ished when statin users were excluded (Table 3). Consequently, 
this finding underscores the importance of established CAC on 
the progression of coronary artery calcification.
4.3 | Limitations
The main strength of this study is a low CV risk profile at 
baseline, with no smokers or diabetic subjects during fol-
low-up. This allows an analysis of the effects of exercise on 
CAC without the influence of pre-existing CV conditions. 
However, when interpreting the results, in particular with 
regard to the multiple regression models, it should be noted 
that the present study was limited to only 61 subjects, with a 
follow-up of > 4 years. Also, the present study is an observa-
tional study without a sedentary control group.
The present study used self-reported retrospective data 
to explore the effects of training volume on CAC. Each 
athlete was asked to report the average amount of exercise 
training per week for the total follow-up period. This was 
done to assure a measure of training volume that would 
cover the whole follow-up period, including seasonal 
fluctuations in training volume and periods of interrupted 
training. However, this data may be subject to recall bias. 
Interestingly, the amount of endurance training hours/
week during the follow-up period was well correlated with 
the reported MET hours/week at inclusion in 2013/14 
(rho  =  0.60, P  <  .001) and moderately at follow-up in 
2018 (rho = 0.39, P = .002). The MET hours/week were 
obtained by the use of the International Physical Activity 
Questionnaire. This questionnaire assesses physical activ-
ity during the last 7 days prior to data registration, thereby 
reflecting the training during the last week prior to the 
North Sea Race. Since the last 7 days prior to a competi-
tion are adapted to improve competitive performance, the 
exercise pattern during this period may not be representa-
tive for the general exercise volume. We therefore believe 
that our global measure of exercise training is better suited 
to assess the impact of high-intensity exercise on CAC. 
Future studies examining the effect of exercise on progres-
sion of CAC should include an exercise log to minimize 
the risk of over- and underestimation of exercise.
Lastly, only 25% of the included subjects had exercise vol-
umes exceeding 6 hours per week. The relationship between 
CAC progression and exercise in middle-aged recreational 
athletes with very high training volumes should be further 
evaluated before concluding with certainty on the effect of 
exercise volume on CAC progression.
5 |  PERSPECTIVE
In this longitudinal follow-up study of highly active middle-
aged recreational athletes with a low CV risk, the progression of 
coronary artery calcification was modest. The volume of high-
intensity exercise was not significantly associated with progres-
sion of CAC. In fact, all subjects with progression of CAC ≥ 10 
Agatston units during follow-up had some CAC or CAD at 
baseline. These findings challenge the belief of a causal effect 
of exercise on coronary artery calcification in masters athletes.
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